This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Massachusetts Institute of Technology. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Emily Chang: Innovator in Pharmaceutical Technologies
Introduction
Emily Chang is a prominent inventor based in Edison, NJ (US), known for her significant contributions to the field of pharmaceuticals. With a total of two patents to her name, she has made remarkable advancements in the development of innovative pharmaceutical products.
Latest Patents
Emily's latest patents include "Layer processing for pharmaceuticals" and "Core-shell magnetic particles and related methods." The first patent describes a method for forming ingestible pharmaceutical products, such as tablets, by processing layers containing pharmaceutically active compositions. This innovative approach allows for the manipulation of layers to create products with enhanced thickness and efficacy. The second patent focuses on core-shell magnetic particles, which consist of a magnetic core and a functional shell. These particles are designed for targeting and removing substances of interest from complex mixtures, showcasing their utility in various applications.
Career Highlights
Emily Chang is affiliated with the Massachusetts Institute of Technology, where she continues to push the boundaries of pharmaceutical research and development. Her work has garnered attention for its potential to improve drug delivery systems and enhance the effectiveness of pharmaceutical products.
Collaborations
Emily has collaborated with notable colleagues, including Trevor Alan Hatton and Bernhardt Levy Trout, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Emily Chang's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor. Her work not only advances pharmaceutical technologies but also paves the way for future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
